FDA work integrity rises, survey says

Share this article:

A Union of Concerned Scientists survey of 997 FDA scientists suggests that agency leaders are helping to boost scientific integrity but still are beset by interference from special interests.

A UCS statement says the 2011 survey shows improvement over what FDA scientists reported in 2006. “Twenty-five percent more respondents, for example, now agree that FDA is acting effectively to protect public health,” it says.

“However, there is room for further improvement,” the statement adds. “FDA scientists express concern on several fronts, including their right to publish research and communicate with the public, the degree of corporate and political influence on regulatory decisions, and the overall transparency and accountability of the agency's decision-making.” Respondents also expressed a fear of retribution for sharing concerns about FDA and were unsure about their right to talk with the press.

FDA's response to the report was through a blog posting by agency chief scientist Jesse Goodman. “Preserving and protecting scientific integrity and working to promote an environment where all feel comfortable expressing their opinions and have confidence in the agency's decision-making must be an ongoing effort and part of our daily life and culture,” he writes.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...